Comparison of Cell Proliferation, Protein, and Glucose Metabolism in Musculoskeletal Tumors in a PET Study

Abstract EN

11C-choline and 18F-FAMT are known to correlate with tumor cell proliferation and amino acid metabolism.

We investigated the ability of 11C-Choline and 18F-FAMT PET in diagnosis of musculoskeletal tumors in thirty-six patients in comparison of 18F-FDG PET.

11C-Choline and 18F-FDG PET were positive in all the malignant tumors (n=13), whereas 18F-FAMT was positive in 11 tumors.

The mean SUVs for malignant tumors were significantly higher than those for benign lesions in all three tracers imaging.

A moderate correlation was found between 11C-Choline and 18F-FDG (r=0.540, P<.05), or 18F-FAMT and FDG (r=0.596, P<.05).

The diagnostic sensitivity and specificity for malignancy were 91.7% and 71.4%, respectively, using 11C-choline with a SUV cut-off of 2.69.

The sensitivity and specificity of 18F-FAMT for malignancy were 66.7% and 85.7%, respectively, using a SUV cut-off of 1.26.

For 18F-FDG, using a SUV cut-off of 2.77, the sensitivity and specificity were 83.3% and 71.4%, respectively.

According to ROC analysis, the ROC curves for 11C-Choline, 18F-FAMT, and 18F-FDG were 0.855, 0.734, and 0.847, respectively.

11C-Choline PET is superior in the visualization of musculoskeletal tumors with high contrast imaging, whereas the combination of 18F-FAMT and 18F-FDG PET provides valuable information for the preoperative planning in patients with musculoskeletal tumors.